FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
FSTX
Delisted
FSTX was delisted on the 8th of March, 2023.
54 hedge funds and large institutions have $35.5M invested in F-star Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
21% less capital invested
Capital invested by funds: $45.1M → $35.5M (-$9.57M)
85% less call options, than puts
Call options by funds: $191K | Put options by funds: $1.31M
Holders
54
Holding in Top 10
1
Calls
$191K
Puts
$1.31M
Top Buyers
| 1 | +$833K | |
| 2 | +$822K | |
| 3 | +$697K | |
| 4 |
Citigroup
New York
|
+$658K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$594K |
Top Sellers
| 1 | -$2.95M | |
| 2 | -$2.8M | |
| 3 | -$1.63M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$819K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$574K |